Along these lines, we employed a 3D tumorsphere in vitro system composed of heterogeneous cancer cell populations, to develop a pharmacological protocol that combined the administration of an LSD1 inhibitor with a drug, so as to efficiently target all cancer cells. Here, KDM1A is linked to cancer.